Date: Tues. June 15, 2021
Time: 9:00 AM EST
The MDMA Conference is a virtual conference exploring the potential of the psychoactive drug MDMA, at the intersection of drug development & safety, clinical care and applications, law & regulation, business & markets, science & research, history & culture.
The MDMA Conference will consist of six keynote talks, on topics such as ‘MDMA-assisted psychotherapy for treating alcohol use disorder’, ‘The Culture of MDMA: The Go-To Medicine in America’s Future’, and ‘MDMA & Clinical Applications’ among various others. Featuring a range of thought and corporate leaders from across the MDMA sector, the discussions will seek to enlighten attendees on ongoing developments within the psychedelics sector as well the latest regulatory and medical developments in the field.
The conference kicks off at 9:00 AM with two keynote presentations:
MDMA-Assisted Psychotherapy for Treating Alcohol Use Disorder
The first address is delivered by Dr. Ben Sessa (Chief Medical Officer, Consultant Psychiatrist and MDMA, Ketamine and Psilocybin Therapist), and covers MDMA-Assisted Psychotherapy for Treating Alcohol Use Disorder. Dr Ben Sessa MBBS (MD) BSc MRCPsych is a consultant child and adolescent psychiatrist who has worked with young people and adults in the field of addictions and trauma-related psychiatry for over 20 years. He has taken part as a study doctor and as a healthy subject both receiving and administering MDMA, psilocybin, LSD, DMT and ketamine in multiple UK research studies.
The Culture of MDMA: The Go-To Medicine in America’s Future
Following that is an address on the culture of MDMA by Charles Wininger, LP, LMHC, a psychotherapist in private practice in New York City, specializing in relationships and communication skills. He is the author of “Listening to Ecstasy: The Transformative Power of MDMA.”
The MDMA Conference is a unique opportunity to build relationships, network with the leading researchers, scientists, doctors, practitioners, and attendees in a comprehensive virtual setting
For more information about the event and how to register, please visit https://ibn.fm/oshyO
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire is part of the InvestorBrandNetwork.